Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP : A clinical consensus statement from the Heart Failure Association of the ESC. / Bayes-Genis, Antoni; Docherty, Kieran F.; Petrie, Mark C.; Januzzi, James L.; Mueller, Christian; Anderson, Lisa; Bozkurt, Biykem; Butler, Javed; Chioncel, Ovidiu; Cleland, John G.F.; Christodorescu, Ruxandra; Del Prato, Stefano; Gustafsson, Finn; Lam, Carolyn S.P.; Moura, Brenda; Pop-Busui, Rodica; Seferovic, Petar; Volterrani, Maurizio; Vaduganathan, Muthiah; Metra, Marco; Rosano, Giuseppe.
In: European Journal of Heart Failure, Vol. 25, No. 11, 2023, p. 1891-1898.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP
T2 - A clinical consensus statement from the Heart Failure Association of the ESC
AU - Bayes-Genis, Antoni
AU - Docherty, Kieran F.
AU - Petrie, Mark C.
AU - Januzzi, James L.
AU - Mueller, Christian
AU - Anderson, Lisa
AU - Bozkurt, Biykem
AU - Butler, Javed
AU - Chioncel, Ovidiu
AU - Cleland, John G.F.
AU - Christodorescu, Ruxandra
AU - Del Prato, Stefano
AU - Gustafsson, Finn
AU - Lam, Carolyn S.P.
AU - Moura, Brenda
AU - Pop-Busui, Rodica
AU - Seferovic, Petar
AU - Volterrani, Maurizio
AU - Vaduganathan, Muthiah
AU - Metra, Marco
AU - Rosano, Giuseppe
N1 - Publisher Copyright: © 2023 European Society of Cardiology.
PY - 2023
Y1 - 2023
N2 - Diagnosing heart failure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure. This document from the Heart Failure Association examines the practical uses of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in various clinical scenarios. The concentrations of NT-proBNP vary according to the patient profile and the clinical scenario, therefore values should be interpreted with caution to ensure appropriate diagnosis. Validated cut-points are provided to rule in or rule out acute heart failure in the emergency department and to diagnose de novo heart failure in the outpatient setting. We also coin the concept of ‘heart stress’ when NT-proBNP levels are elevated in an asymptomatic patient with risk factors for heart failure (i.e. diabetes, hypertension, coronary artery disease), underlying the development of cardiac dysfunction and further increased risk. We propose a simple acronym for healthcare professionals and patients, FIND-HF, which serves as a prompt to consider heart failure: Fatigue, Increased water accumulation, Natriuretic peptide testing, and Dyspnoea. Use of this acronym would enable the early diagnosis of heart failure. Overall, understanding and utilizing NT-proBNP levels will lead to earlier and more accurate diagnoses of heart failure ultimately improving patient outcomes and reducing healthcare costs.
AB - Diagnosing heart failure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure. This document from the Heart Failure Association examines the practical uses of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in various clinical scenarios. The concentrations of NT-proBNP vary according to the patient profile and the clinical scenario, therefore values should be interpreted with caution to ensure appropriate diagnosis. Validated cut-points are provided to rule in or rule out acute heart failure in the emergency department and to diagnose de novo heart failure in the outpatient setting. We also coin the concept of ‘heart stress’ when NT-proBNP levels are elevated in an asymptomatic patient with risk factors for heart failure (i.e. diabetes, hypertension, coronary artery disease), underlying the development of cardiac dysfunction and further increased risk. We propose a simple acronym for healthcare professionals and patients, FIND-HF, which serves as a prompt to consider heart failure: Fatigue, Increased water accumulation, Natriuretic peptide testing, and Dyspnoea. Use of this acronym would enable the early diagnosis of heart failure. Overall, understanding and utilizing NT-proBNP levels will lead to earlier and more accurate diagnoses of heart failure ultimately improving patient outcomes and reducing healthcare costs.
KW - Heart failure
KW - Natriuretic peptides
KW - NT-proBNP
U2 - 10.1002/ejhf.3036
DO - 10.1002/ejhf.3036
M3 - Journal article
C2 - 37712339
AN - SCOPUS:85172245578
VL - 25
SP - 1891
EP - 1898
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
SN - 1567-4215
IS - 11
ER -
ID: 379160361